Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

Автор: ThyCa: Thyroid Cancer Survivors' Association, Inc.

Загружено: 2023-12-08

Просмотров: 524

Описание:

212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets. Presented by Daniel Bowles, MD, Medical Oncologist, and Mabel Ryder, MD, Endocrinologist. This video was recorded during the 26th International Thyroid Cancer Survivors' Conference that was held Oct 13-15, 2023 in Denver, Colorado, USA. This event was hosted by ThyCa: Thyroid Cancer Survivors' Association, Inc. The content is not to be used as medical advice, but rather as education. Please seek the care of your own medical team.

212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

231 The changing landscape of papillary & follicular thyroid cancer: What do patients need to know?

231 The changing landscape of papillary & follicular thyroid cancer: What do patients need to know?

Radioactive iodine (RAI) therapy for RAI-refractory disease: “redifferentiation” with Dr. Sherman

Radioactive iodine (RAI) therapy for RAI-refractory disease: “redifferentiation” with Dr. Sherman

331 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

331 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

Advanced Treatments in 2025 Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 6

Advanced Treatments in 2025 Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 6

Более 16 лет без рака благодаря иммунотерапии: история меланомы Шэрон Белвин

Более 16 лет без рака благодаря иммунотерапии: история меланомы Шэрон Белвин

Kim był Jan Kulczyk z pochodzenia? Sekret najbogatszego Polaka!

Kim był Jan Kulczyk z pochodzenia? Sekret najbogatszego Polaka!

Advances in management of anaplastic thyroid cancer advances in targeted treatment Kate Newbold

Advances in management of anaplastic thyroid cancer advances in targeted treatment Kate Newbold

“Genetic Changes in Thyroid Cancer”, the Annual Blackard Lecture, presented by Dr. Matthew Ringel

“Genetic Changes in Thyroid Cancer”, the Annual Blackard Lecture, presented by Dr. Matthew Ringel

Coronary Artery Disease Regression - Insights on Mechanisms & How to Achieve: Stephen Kopecky, M.D.

Coronary Artery Disease Regression - Insights on Mechanisms & How to Achieve: Stephen Kopecky, M.D.

Update on Management of Medullary Thyroid Cancer w/ Dr. Hu

Update on Management of Medullary Thyroid Cancer w/ Dr. Hu

Prostate Cancer Recurrence | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 2

Prostate Cancer Recurrence | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 2

New Hope for Advanced Thyroid Cancer Patients

New Hope for Advanced Thyroid Cancer Patients

Основные моменты конференции ESMO 2025 по раку легких: MDT-BRIDGE, FLAURA2, SOHO-01, Beamion LUNG-1

Основные моменты конференции ESMO 2025 по раку легких: MDT-BRIDGE, FLAURA2, SOHO-01, Beamion LUNG-1

KONTRA #21 Rymanowski, Budzisz, gen. Komornicki: Świat według Donalda

KONTRA #21 Rymanowski, Budzisz, gen. Komornicki: Świat według Donalda

Targeted therapies (i.e.: multi-kinase inhibitors, RET, NTRK inhibitors) in advanced disease. 251

Targeted therapies (i.e.: multi-kinase inhibitors, RET, NTRK inhibitors) in advanced disease. 251

322 Management of initial, persistent, or recurrent thyroid cancer

322 Management of initial, persistent, or recurrent thyroid cancer

Spring 2025 Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Findings (Chicago)

Spring 2025 Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Findings (Chicago)

The ABCs of thyroid cancer with Dr.  Bischoff (131)

The ABCs of thyroid cancer with Dr. Bischoff (131)

Dr Sara Frederico, Current trials at St Jude

Dr Sara Frederico, Current trials at St Jude

Management of Differentiated Thyroid Carcinoma in the Era of Targeted Therapy

Management of Differentiated Thyroid Carcinoma in the Era of Targeted Therapy

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: infodtube@gmail.com